Tango Therapeutics, Inc.

closed
TNGXSEC EDGARCIK: 0001819133|BCTG Holdings, LLC•Biotechnology

Capital Structure & Economics

Trust Size$125,000,000
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

No Warrants / No Drag
Public Trust Allocation$125,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJul 30, 2020
SearchingTarget Pending
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyTango
  • SectorBiotechnology
  • Announced Deal Size$550,000,000

Board & Officers

  • Malte PetersCEO
  • Daniella Beckman(2)
    Director
  • Barbara WeberDirector
  • Alexis Borisy(2)
    Director
  • Lesley Ann CalhounDirector
  • Kanishka PothulaDirector
  • John KetchumDirector
  • Sung LeeDirector
  • Mace RothenbergDirector
  • Aaron I. DavisDirector
  • Christopher FuglesangDirector
  • Michael BeauchampDirector
  • Andrew EllisDirector
  • Carole L. NuechterleinDirector
  • Richard HeymanDirector
  • Charles M. BaumDirector
  • Jamie G. ChristensenDirector
  • Christopher Fuglesang, Ph.D., J.D.Director
  • Andrew Ellis, M.D., J.D.Director
  • Carole L. Nuechterlein, J.D.Director
  • Richard Heyman, Ph.D.Director
  • Charles M. Baum, M.D., Ph.D.Director
  • Jamie G. Christensen, Ph.D.Director

Advanced Structuring Terms

Target SectorsBiotechnology

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction